February 12, 19, 26
10:00-12:00pm |
Robert Gentleman, Regression Modeling
These sessions will cover least squares regression (inference, splines, diagnostics), logistic regression (inference, splines, diagnostics), and a bit on false discovery rate (FDR). The instructor will use R but attendees should easily be able to use other packages that have suitable functionality. |
Hybrid, CLSB 11081
Evaluation |
March 12
10:00-12:00pm |
Anne O’Neill, Introduction to Clinical Trials
The first part of this session provides a broad overview of phase I, II, and III clinical trials, randomization, stratification and the most common phase I design, a 5-10 minute break close to 10:45/11am, then an introduction to phase II clinical trials, collaborations with investigators and things to keep in mind when collaborating and designing, examples of some common designs and some of the in house software. In an effort to provide this material before the Phase II clinical trial design session on March 19th and to keep to the 2 hour format, this session on March 12th reviews fewer examples in detail (although all the examples would remain in the slide deck). The session on March 19th provides and reviews more examples of phase II designs. |
Virtual only
Evaluation
|
March 19
9:30-11:30am |
Sandra Lee, Phase II Trial Designs
The main goals of phase II clinical trials are to assess the preliminary efficacy of a new regimen and decide if the level of efficacy warrants a phase III study. The study designs of phase II studies have become more complex concerning the study endpoints, use of randomizations, and implementation of interim analyses. In this session, we will review general study considerations for phase II clinical trials and evaluate the study designs. Examples from phase II clinical trials of ECOG-ACRIN studies will be presented and discussed. Everyone is welcome and being a part of ECOG-ACRIN is not a prerequisite to attend the session. |
Hybrid, CLSB 11081
Evaluation
|
April 2
11-12pm |
Haesook Kim, Overview of Data Analysis
This is an informal session providing an overview of statistical data analysis, drawing from my 30+ years of experience. This session covers topics including descriptive analysis (with an emphasis on graphical presentation), regression analysis (univariate and multivariate linear regression, logistic regression, proportional hazards regression, and common issues such as collinearity, model fitting/assessment, and bootstrapping), as well as other related analyses (missing data analysis, propensity score adjustment, PCA, correlation analysis, clustering, and more) |
Hybrid, CLSB 11081
Evaluation |
April 9
11-1pm |
Haesook Kim, Survival Analysis I
Topics included in this session are introduction of survival analysis, terminologies (event, time origin, time scale, censoring), hazard function, survival function, properties of survival time distribution, Kaplan-Meier method, calculation of confidence interval, estimation of median survival time, log-rank test, mantel-byar test. Each topic will be illustrated with numerous real data examples along with the provision of SAS and R codes. For more information on these topics, attendees are encouraged to refer to the 2023 training notes. Please note these are only available to Data Science employees; if you wish to view please contact Anne O’Neill. |
Virtual only
Evaluation |
April 16
10-1pm |
Patient Registration and Randomization at ECOG-ACRIN (with an introduction to RANCSH program for all members of DS)
Session leads: Ju-Whei Lee, Amie Kim, David Hong, Yue Zheng
This training session consists of two parts. Part I is to familiarize the audience with the ECOG-ACRIN Patient Registration System (PRS) software and processes, policies, procedures, timelines for study activation/modification/accrual termination, and the responsibilities of study statisticians and the PRS Team personnel in the process of various study milestones. Part I will also cover methods on how to monitor ECOG-ACRIN study accruals and examples of how to set up accrual reporting and notifications (as part of the ECOG-ACRIN study activation form) in response to various study designs. Everyone is welcome to attend this session, but this part probably is more relevant to the ECOG-ACRIN statisticians.
Part II is a more general session, covering how treatments are assigned, with the focus on the method of permuted blocks for randomization and how institutional balance (if requested) works here. We’ll also demonstrate how to use the RANSCH program to generate permuted blocks for treatment assignment in randomized trials. RANSCH is a program locally available on our computing server. Anyone who is interested in learning about stratification and in using the RANSCH program is welcome to attend, being a member of ECOG-ACRIN is not a pre-requisite. For planning your time, Part II would be covered from approximately 11:40 to 1pm. There is a planned 5-10 minute break in between Part I and Part II. |
Hybrid, CLSB 11081
Evaluation |
June 4
10-12pm |
Anne O’Neill, Introduction to Clinical Trials: Phase III Clinical Trials
This is a continuation of the March 12th Introduction to Clinical Trials training session with further introduction to Phase III clinical trials, things to keep in mind when collaborating and designing, and an example using common in-house software. If time remains, further examples of trial results and stratification will be reviewed. Attendance at the March 12th Introduction to Clinical Trials session is helpful but not required. |
Hybrid, CLSB 11081
Evaluation |
June 11
10-12pm |
Anne O’Neill, Introduction to Clinical Trials: Reading a Protocol, CRFs, database, RECIST, AE data – Part 1
This training provides an introduction to parts of the following: Protocol, Case Report Forms (CRFs), clinical trials database, RECIST criteria, and response data, all from a statistical perspective. Working with and/or viewing data is part of the session; therefore CITI certification is required. Attendance at the March 12 and June 4 Introduction to Clinical Trials Phase I,II, and III training sessions is helpful but not required. |
Hybrid, CLSB 11081
Evaluation |
June 18
10-11:30am |
Anne O’Neill, Introduction to Clinical Trials: Reading a Protocol, CRFs, database, RECIST, AE data – Part 2
This is a continuation of the June 11th training session. This training provides an introduction to parts of the following: Common Terminology Criteria (CTCAE), clinical trials database (adverse event tables), and adverse event analyses from a statistical perspective. Working with and/or viewing data is part of the session; therefore CITI certification is required. Attendance at the March 12, June 4, and June 11 Introduction to Clinical Trials sessions is helpful but not required. |
Hybrid, CLSB 11081
Evaluation |
June 18
1-4pm |
Erica Holdmore, Statistics for Computational Biology Projects
Statistics is an important tool for computational biologists because it helps us quantitatively understand and analyze biological data. This interactive training session will cover an introduction to statistical concepts. Topics will include: experimental design, data cleaning, common analysis methods (logistic regression, ANOVA, GLM, multiple comparisons), and interpreting results. |
Zoom only
Evaluation |
June 25
10-12pm |
Jonathan Larson, Mixed Models
This session will introduce linear mixed effects models, including implementation in R and interpretation of results. Theory will be presented to the extent that it aids decision-making in analysis. Registrants should have an understanding of linear regression. There is time for Q&A throughout the session and at the end. |
Zoom only
Evaluation |
July 16
1-4pm |
Jared Brown, Deeper Differential Expression Analysis with Shrinkage Correction
Differential expression (alternately abundance) analysis is regularly a core tool in identifying and quantifying differences between and across groups in -omics data. In this workshop session with follow-along analysis scripts we will take a deeper look at the models underlying differential expression analysis with the particular example being the DESeq2 framework. We will examine questions around design specification, the proper use of pre-computed offsets like normalization corrections, parameter estimation and testing, and robust false discovery rate correction through post-hoc shrinkage. Examples highlighting how these approaches differ across datasets will be drawn from bulk RNAseq, single-cell RNAseq, and ChIPseq. |
Zoom only
Evaluation |
September 9
10am-11:30pm |
Anne O’Neill, INFORM Clinical Trials Database (Introduction to Access and Authorization)
INFORM houses data from DF/HCC clinical trials which utilize electronic data capture (eDC). This training will provide a general overview of the INFORM Clinical Trials Database itself, from a statistical perspective, as well as the set-up needed to access data, including how to obtain authorization. Documentation for the available programs to interact with and pull data is also provided. This training is relevant to you if you are assigned to a clinical trial whose corresponding clinical data are in INFORM and you have not yet verified your access or authorization. Please reach out to Anne ONeill if you have questions about the training or if it would be applicable to the work that you do. |
Hybrid, CLSB 11065
Registration |
September 10
10am-12pm |
Jonathan Larson, Generalized Linear Mixed Effects Models
This session will extend the material from the Mixed Models training on June 25 (available at https://youtu.be/AY4FrL0xb4Q) to outcomes that are not normally distributed, e.g., count and binary outcomes. To recap, mixed models are one method for analyzing correlated data. This can include longitudinal data, when multiple observations are taken on the same unit over time; hierarchical data, such as when multiple patients are seen by the same doctor; and other forms of grouped data. We will cover implementation in R with a real data set and enough theory to guide decision-making. We strongly encourage in-person attendance. |
Hybrid, CLSB 11081
Registration |
September 17
10am-12pm |
Brian Silverstein, Introduction to Unix |
Hybrid, CLSB 11081
Registration |
October 1
10am-12pm |
Erica Feick, Time Management: Strategies for Productivity and Focus
In today’s world, managing time effectively is more critical than ever. This talk explores the art and science of time management, offering actionable strategies to help you shift your focus from being busy to being effective. We will delve into established productivity methods (for example, GTD, Pomodoro, time blocking) and provide strategies to maintain focus in a world full of distractions. Whether you’re looking to reduce stress, improve productivity, or make better decisions, this session will equip you with the tools to take control of your time and achieve your goals. Learn ways to transform the way you manage your most valuable resource—your time.
|
Hybrid, CLSB 11081
Registration |
October 8
10am-12pm |
Miki Horiguchi, Insights from Journal Reviewers and Editors |
Hybrid, CLSB 11081
Registration |
October 15
10am-12pm |
Jonathan Larson, Generalized Estimating Equations (GEE)
This session will cover a method for analyzing correlated data that is entirely distinct from mixed models. GEE is semi-parametric, whereas mixed models are fully parametric, and GEE estimates marginal parameters, whereas mixed models (usually) estimate conditional parameters. Because we will compare and contrast these two major approaches, it will be helpful for participants to have attended the training sessions on June 25 and September 10 or watched their videos. However, understanding mixed models is not a prerequisite for understanding GEE. We will cover implementation in R with a real data set and enough theory to guide decision-making. We strongly encourage in-person attendance. |
Hybrid, CLSB 11081
Registration |
November 5
10am-12pm |
Hajime Uno / Angel Cronin, Restricted Mean Survival Time Part I |
Hybrid, CLSB 11081
|
November 12
10am-12pm |
Hajime Uno / Angel Cronin, Restricted Mean Survival Time Part II |
Hybrid, CLSB 11081
|